We Offer Worldwide Shipping
Login Wishlist

Oleonuezhenide

$784

  • Brand : BIOFRON

  • Catalogue Number : BD-P0914

  • Specification : 98.0%(HPLC&TLC)

  • CAS number : 112693-21-7

  • PUBCHEM ID : 6443262

  • Volume : 25mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BD-P0914

Analysis Method

HPLC,NMR,MS

Specification

98.0%(HPLC&TLC)

Storage

2-8°C

Molecular Weight

Appearance

Powder

Botanical Source

Structure Type

Iridoids

Category

Standards;Natural Pytochemical;API

SMILES

CC=C1C(C(=COC1OC2C(C(C(C(O2)CO)O)O)O)C(=O)OC)CC(=O)OCC3C(C(C(C(O3)OCCC4=CC=C(C=C4)O)OC(=O)CC5C(=COC(C5=CC)OC6C(C(C(C(O6)CO)O)O)O)C(=O)OC)O)O

Synonyms

2-(4-Hydroxyphenyl)ethyl 2,6-bis-O-{[(2S,3E,4S)-3-ethylidene-2-(β-D-glucopyranosyloxy)-5-(methoxycarbonyl)-3,4-dihydro-2H-pyran-4-yl]acetyl}-β-D-glucopyranoside/β-D-Glucopyranoside, 2-(4-hydroxyphenyl)ethyl, 2,6-bis[2-[(2S,3E,4S)-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetate]/Oleonuezhenide

IUPAC Name

methyl (5E,6S)-5-ethylidene-4-[2-[[(2R,3S,4S,5R,6R)-5-[2-[(2S,3E)-3-ethylidene-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-4-yl]acetyl]oxy-3,4-dihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate

Applications

Density

1.6±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

325.7±27.8 °C

Boiling Point

1149.3±65.0 °C at 760 mmHg

Melting Point

InChl

InChI=1S/C48H64O27/c1-5-22-24(26(42(62)64-3)17-68-44(22)74-46-39(60)36(57)33(54)28(15-49)70-46)13-31(52)67-19-30-35(56)38(59)41(48(72-30)66-12-11-20-7-9-21(51)10-8-20)73-32(53)14-25-23(6-2)45(69-18-27(25)43(63)65-4)75-47-40(61)37(58)34(55)29(16-50)71-47/h5-10,17-18,24-25,28-30,33-41,44-51,54-61H,11-16,19H2,1-4H3/b22-5+,23-6+/t24?,25?,28-,29-,30-,33-,34-,35-,36+,37+,38+,39-,40-,41-,44+,45+,46+,47+,48-/m1/s1

InChl Key

MFZDFMOKBMJUGB-CWERYYTKSA-N

WGK Germany

RID/ADR

HS Code Reference

2933990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:112693-21-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

31355335

Abstract

The rodent Peromyscus leucopus is the natural reservoir of several tick-borne infections, including Lyme disease. To expand the knowledge base for this key species in life cycles of several pathogens, we assembled and scaffolded the P. leucopus genome. The resulting assembly was 2.45 Gb in total length, with 24 chromosome-length scaffolds harboring 97% of predicted genes. RNA sequencing following infection of P. leucopus with Borreliella burgdorferi, a Lyme disease agent, shows that, unlike blood, the skin is actively responding to the infection after several weeks. P. leucopus has a high level of segregating nucleotide variation, suggesting that natural resistance alleles to Crispr gene targeting constructs are likely segregating in wild populations. The reference genome will allow for experiments aimed at elucidating the mechanisms by which this widely distributed rodent serves as natural reservoir for several infectious diseases of public health importance, potentially enabling intervention strategies.

Title

The genome of Peromyscus leucopus, natural host for Lyme disease and other emerging infections

Author

Anthony D. Long,1,* James Baldwin-Brown,1,2 Yuan Tao,1 Vanessa J. Cook,3 Gabriela Balderrama-Gutierrez,4 Russell Corbett-Detig,5 Ali Mortazavi,4 and Alan G. Barbour3,*

Publish date

2019 Jul

PMID

23794863

Abstract

The Indo-Malayan and Palearctic species of Oxyscelio (Hymenoptera: Platygastridae s.l.) are revised. A total of 90 species are recognized as valid, 19 of which are redescribed – Oxyscelio acutiventris (Kieffer), Oxyscelio brevinervis (Kieffer), Oxyscelio carinatus (Kieffer), Oxyscelio ceylonensis (Dodd), Oxyscelio consobrinus (Kieffer), Oxyscelio crassicornis (Kieffer), Oxyscelio cupularis (Kieffer), Oxyscelio dorsalis (Kieffer), Oxyscelio excavatus (Kieffer), Oxyscelio flavipennis (Kieffer), Oxyscelio florus Kononova, Oxyscelio foveatus Kieffer, Oxyscelio kiefferi Dodd, Oxyscelio magnus (Kieffer), Oxyscelio marginalis (Kieffer), Oxyscelio naraws Kozlov & Lê, Oxyscelio perpensus Kononova, Oxyscelio rugosus (Kieffer) and Oxyscelio spinosiceps (Kieffer), and 71 which are described as new – Oxyscelio aclavae Burks, sp. n., Oxyscelio amrichae Burks, sp. n., Oxyscelio anguli Burks, sp. n., Oxyscelio angustifrons Burks, sp. n., Oxyscelio angustinubbin Burks, sp. n., Oxyscelio arcus Burks, sp. n., Oxyscelio arvi Burks, sp. n., Oxyscelio asperi Burks, sp. n., Oxyscelio aureamediocritas Burks, sp. n., Oxyscelio bipunctuum Burks, sp. n., Oxyscelio brevidentis Burks, sp. n., Oxyscelio caesitas Burks, sp. n., Oxyscelio capilli Burks, sp. n., Oxyscelio capitis Burks, sp. n., Oxyscelio cavinetrion Burks, sp. n., Oxyscelio chimaerae Burks, sp. n., Oxyscelio codae Burks, sp. n., Oxyscelio convergens Burks, sp. n., Oxyscelio cordis Burks, sp. n., Oxyscelio crateris Burks, sp. n., Oxyscelio crebritas Burks, sp. n., Oxyscelio crustum Burks, sp. n., Oxyscelio cuculli Burks, sp. n., Oxyscelio cyrtomesos Burks, sp. n., Oxyscelio dasymesos Burks, sp. n., Oxyscelio dasynoton Burks, sp. n., Oxyscelio dermatoglyphes Burks, sp. n., Oxyscelio doumao Burks, sp. n., Oxyscelio fistulae Burks, sp. n., Oxyscelio flabellae Burks, sp. n., Oxyscelio flaviventris Burks, sp. n., Oxyscelio fodiens Burks, sp. n., Oxyscelio fossarum Burks, sp. n., Oxyscelio fossularum Burks, sp. n., Oxyscelio genae Burks, sp. n., Oxyscelio granorum Burks, sp. n., Oxyscelio granuli Burks, sp. n., Oxyscelio greenacus Burks, sp. n., Oxyscelio halmaherae Burks, sp. n., Oxyscelio intermedietas Burks, sp. n., Oxyscelio jaune Burks, sp. n., Oxyscelio jugi Burks, sp. n., Oxyscelio kramatos Burks, sp. n., Oxyscelio labis Burks, sp. n., Oxyscelio lacunae Burks, sp. n., Oxyscelio latinubbin Burks, sp. n., Oxyscelio latitudinis Burks, sp. n., Oxyscelio limae Burks, sp. n., Oxyscelio longiventris Burks, sp. n., Oxyscelio mesiodentis Burks, sp. n., Oxyscelio mollitia Burks, sp. n., Oxyscelio nasolabii Burks, sp. n., Oxyscelio nodorum Burks, sp. n., Oxyscelio noduli Burks, sp. n., Oxyscelio nubbin Burks, sp. n., Oxyscelio obsidiani Burks, sp. n., Oxyscelio ogive Burks, sp. n., Oxyscelio operimenti Burks, sp. n., Oxyscelio peludo Burks, sp. n., Oxyscelio planocarinae Burks, sp. n., Oxyscelio praecipitis Burks, sp. n., Oxyscelio reflectens Burks, sp. n., Oxyscelio regionis Burks, sp. n., Oxyscelio sinuum Burks, sp. n., Oxyscelio spinae Burks, sp. n., Oxyscelio striarum Burks, sp. n., Oxyscelio tecti Burks, sp. n., Oxyscelio unguis Burks, sp. n., Oxyscelio vadorum Burks, sp. n., Oxyscelio vittae Burks, sp. n. and Oxyscelio zeuctomesos. Neotypes are designated for nine species, including the type species O. foveatus Kieffer, Oxyscelio brevinervis (Kieffer), Oxyscelio bifurcatus (Kieffer), Oxyscelio frontalis (Kieffer), Oxyscelio crassicornis (Kieffer), Oxyscelio cupularis (Kieffer), Oxyscelio foveatus Kieffer, Oxyscelio kiefferi Dodd, Oxyscelio magnus (Kieffer) and Oxyscelio marginalis (Kieffer). Oxyscelio bifurcatus (Kieffer) syn. n. and Oxyscelio frontalis (Kieffer) syn. n. are synonymized under Oxyscelio consobrinus (Kieffer). The fauna is divided into 13 species groups, with six species unplaced to a group. A phylogenetic analysis employing 73 morphological characters did not find most of these groups to be monophyletic, but they are retained to aid in specimen identification. Potential biogeographical patterns are discussed, including regional variation in surface sculpture and a morphological link between Sri Lankan and Australian species.

KEYWORDS

Platygastroidea, Scelionidae, Oxyscelio, Scelioninae, key, revision, database, parasitoid

Title

Systematics of the parasitic wasp genus Oxyscelio Kieffer (Hymenoptera, Platygastridae s.l.), Part I: Indo-Malayan and Palearctic fauna

Author

Roger A. Burks,1 Lubomir Masner,2 Norman F. Johnson,1 and Andrew D. Austin3

Publish date

2013

PMID

31022369

Abstract

Introduction
Little is known about trends in the overall combined burden of fatal and nonfatal cerebrovascular disease events in the United States. Our objective was to describe the combined burden by age, sex, and region from 2006 through 2014.

Methods
We used data on adults aged 35 and older from 2006 through 2014 Nationwide Emergency Department Sample, National Inpatient Sample of the Healthcare Cost and Utilization Project, and the National Vital Statistics System. We calculated age-standardized cerebrovascular disease event rates by using the 2010 US Census population. Trends in rates were assessed by calculating the relative percentage change (RPC) between 2006 and 2014, and by using Joinpoint to obtain P values for overall trends.

Results
The age-standardized rate increased significantly for total cerebrovascular disease events (primary plus comorbid events) from 1,050 per 100,000 in 2006 to 1,147 per 100,000 in 2014 (P < .05 for trend). Treat-and-release emergency department visits with comorbid cerebrovascular disease events increased significantly, from 114 per 100,000 in 2006 to 213 per 100,000 in 2014 (RPC of 87%, P < .05 for trend). Significant rate increases were identified among adults aged 35 to 64 with an RPC of 19% in primary cerebrovascular disease events, 48% in comorbid cerebrovascular disease events, and 36% in total events. Conclusion Our findings have important implications for the increasing cerebrovascular disease burden among adults aged 35 to 64. Focused prevention strategies should be implemented, especially among young adults who may be unaware of existing modifiable risk factors.

Title

The Burden of Cerebrovascular Disease in the United States

Author

Xin Tong, MPH,corresponding author 1 Quanhe Yang, PhD, 1 Matthew D. Ritchey, PT, DPT, OCS, MPH, 1 Mary G. George, MD, MSPH, 1 Sandra L. Jackson, PhD, MPH, 1 Cathleen Gillespie, MS, 1 and Robert K. Merritt, MA 1

Publish date

2019;